Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Shuyang Sun

Showing results (51-60 of 90) with videos related to

Pageof 9
Sort By:
Advanced Materials (Deerfield Beach, Fla.)|January 19, 2023
A Physiologically Responsive Nanocomposite Hydrogel for Treatment of Head and Neck Squamous Cell Carcinoma via Proteolysis-Targeting Chimeras Enhanced ImmunotherapyYaping Wu, Xiaowei Chang, Guizhu Yang, et al.
Water Research|December 22, 2014
Gravity-driven membrane filtration as pretreatment for seawater reverse osmosis: linking biofouling layer morphology with flux stabilizationEbrahim Akhondi, Bing Wu, Shuyang Sun, et al.
Advanced Science (Weinheim, Baden-Wurttemberg, Germany)|July 5, 2023
Synergized Tricomponent All-Inorganics Solid Electrolyte for Highly Stable Solid-State Li-Ion BatteriesGuixiang Xu, Xin Zhang, Shuyang Sun, et al.
Food Chemistry: X|December 10, 2024
Effect of five lactic acid bacteria on the flavor quality of fermented sweet potato juiceBin Liang, Xue Bai, Yunfan Wang, et al.
International Journal of Nanomedicine|April 1, 2021
Nanobody: A Small Antibody with Big Implications for Tumor Therapeutic StrategyShuyang Sun, Ziqiang Ding, Xiaomei Yang, et al.
Nature Communications|February 25, 2021
The tumor therapy landscape of synthetic lethalityBiyu Zhang, Chen Tang, Yanli Yao, et al.
Clinical and Translational Radiation Oncology|April 25, 2023
Adjuvant PD-1 antibody in recurrent, previously irradiated oral cavity cancer treated with salvage surgeryShengjin Dou, Lin Zhang, Rongrong Li, et al.
Theranostics|March 4, 2017
Targeting and Regulating of an Oncogene via Nanovector Delivery of MicroRNA using Patient-Derived XenograftsShuyang Sun, Yilong Wang, Rong Zhou, et al.
Theranostics|May 1, 2019
Repurposing Ponatinib as a Potent Agent against <i>KIT</i> Mutant MelanomasYong Han, Ziyue Gu, Jing Wu, et al.
Journal of Hematology & Oncology|November 30, 2023
Nanobody-based trispecific T cell engager (Nb-TriTE) enhances therapeutic efficacy by overcoming tumor-mediated immunosuppressionZiqiang Ding, Shuyang Sun, Xuan Wang, et al.
Pageof 9

Showing results (51-60 of 90) with videos related to

Sort By:
Pageof 9
Advanced Materials (Deerfield Beach, Fla.)|January 19, 2023
A Physiologically Responsive Nanocomposite Hydrogel for Treatment of Head and Neck Squamous Cell Carcinoma via Proteolysis-Targeting Chimeras Enhanced ImmunotherapyYaping Wu, Xiaowei Chang, Guizhu Yang, et al.
Water Research|December 22, 2014
Gravity-driven membrane filtration as pretreatment for seawater reverse osmosis: linking biofouling layer morphology with flux stabilizationEbrahim Akhondi, Bing Wu, Shuyang Sun, et al.
Advanced Science (Weinheim, Baden-Wurttemberg, Germany)|July 5, 2023
Synergized Tricomponent All-Inorganics Solid Electrolyte for Highly Stable Solid-State Li-Ion BatteriesGuixiang Xu, Xin Zhang, Shuyang Sun, et al.
Food Chemistry: X|December 10, 2024
Effect of five lactic acid bacteria on the flavor quality of fermented sweet potato juiceBin Liang, Xue Bai, Yunfan Wang, et al.
International Journal of Nanomedicine|April 1, 2021
Nanobody: A Small Antibody with Big Implications for Tumor Therapeutic StrategyShuyang Sun, Ziqiang Ding, Xiaomei Yang, et al.
Nature Communications|February 25, 2021
The tumor therapy landscape of synthetic lethalityBiyu Zhang, Chen Tang, Yanli Yao, et al.
Clinical and Translational Radiation Oncology|April 25, 2023
Adjuvant PD-1 antibody in recurrent, previously irradiated oral cavity cancer treated with salvage surgeryShengjin Dou, Lin Zhang, Rongrong Li, et al.
Theranostics|March 4, 2017
Targeting and Regulating of an Oncogene via Nanovector Delivery of MicroRNA using Patient-Derived XenograftsShuyang Sun, Yilong Wang, Rong Zhou, et al.
Theranostics|May 1, 2019
Repurposing Ponatinib as a Potent Agent against <i>KIT</i> Mutant MelanomasYong Han, Ziyue Gu, Jing Wu, et al.
Journal of Hematology & Oncology|November 30, 2023
Nanobody-based trispecific T cell engager (Nb-TriTE) enhances therapeutic efficacy by overcoming tumor-mediated immunosuppressionZiqiang Ding, Shuyang Sun, Xuan Wang, et al.
Pageof 9